Ubisoft Insists MIA Splinter Cell Remake Still in Development Despite Fresh Layoffs

Ubisoft will cut 40 roles at its Ubisoft Toronto studio as part of a global cost-savings and project discontinuation program, though the company says development on the long-awaited Splinter Cell remake continues. The move follows broader recent actions including the cancellation of several projects (notably the Prince of Persia: The Sands of Time Remake), full closures of Ubisoft Stockholm and Halifax, and plans to cut up to 200 roles at Paris HQ; the Toronto studio remains a co-development partner on Rainbow Six and other projects. While the reassurance on Splinter Cell reduces immediate product-risk concerns, the ongoing restructurings underscore execution and cost pressures across Ubisoft's studio network.

Analysis

Market structure: Ubisoft's incremental layoffs plus cancellations signal continued portfolio pruning across mid‑to‑large Western publishers; winners are capitalized, live‑service incumbents (ATVI, TTWO, EA) that can redeploy IP and scale costs, while smaller studios and mid‑cap developers (Embracer, some listed independents) face margin and cash‑flow pressure. Expect modest reallocation of share to big-cap publishers over 6–18 months and a compression of valuations for highly project‑dependent names by 10–30% if more cancellations follow.

Risk assessment: Tail risks include a wider wave of cancellations or union/PR escalations that hit near‑term bookings (low‑probability, high‑impact) and potential write‑downs that could worsen leverage for acquisitive groups; watch liquidity covenants for weaker balance sheets over next 3–12 months. Near term (days–weeks) sentiment moves likely; medium term (quarters) fundamentals shift via cost savings and IP cadence; long term (years) depends on hit rates for remakes/live services.

Trade implications: Tactical opportunities favor idiosyncratic long on selectively cost‑cutting publishers and hedged option exposure; consider 12‑month call spreads on Ubisoft-sized exposure (convex upside if remakes revive) and pair trades shorting levered mid‑caps like Embracer vs long ATVI/TTWO. Rotation from small devs into diversified live‑service names and gaming ETFs (GAMR/HERO) is warranted over 3–12 months, but size positions conservatively (1–3% portfolio each).

Contrarian angles: The market may underprice the near‑term earnings uplift from aggressive cost savings — if Ubisoft reduces opex 5–10% this fiscal year, EBITDA could beat consensus by 10–20%, providing asymmetric upside. Conversely, consensus may underestimate cumulative IP cancellations; hedge with low‑cost puts or spread sellers and treat positive dev updates (e.g., Splinter Cell release window) as binary catalysts for re‑rating within 6–12 months.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Ubisoft (EPA: UBI.PA or OTC: UBSFY) via a 12‑month call spread (buy 25% OTM call, sell 50% OTM call) sized so max premium = 1% portfolio; target +40–60% upside over 12 months, cut if Ubisoft issues >10% FY revenue guidance reduction or cancels core IP.
• Initiate a pair trade: long UBI.PA 2% vs short Embracer (STO: EMBRAC‑B) 1.5% for 3–12 months — thesis: Ubisoft benefits from restructuring while Embracer remains leverage‑sensitive to cancellations; set stop‑loss at 20% adverse move on pair.
• Overweight large-cap live‑service publishers (ATVI, TTWO, EA) by +1–2% combined vs underweight mid/small‑caps by −2–3% over next 6–12 months to capture scale advantages and reallocation; rebalance if sector ETF GAMR outperforms by >10% in 90 days.
• Use options insurance: buy 3‑month 10–15% OTM puts on a small‑cap gaming basket or GAMR (size 0.5–1% portfolio) to protect against a news‑driven downdraft from further cancellations or negative earnings surprises; reassess after Ubisoft quarterly results (~next 60–90 days).